According to the current analysis of Reports and Data, the global Cord Blood Banking Services Market was valued at USD 47.39 Billion in 2020 and is expected to reach USD 111.13 Billion by year 2028, at a CAGR of 11.10%. Umbilical cord blood (UCB) was once considered a waste product and was discarded with the placenta after delivery. With advances in medicine, it was found to be a rich source of life-saving hematopoietic stem cells and has saved many lives in the recent years. Cord blood stem cell transplantation are performed at various centers all across the world for a variety of diseases including genetic, hematologic, immunologic, metabolic, and oncologic disorders. Moreover, a number of cord blood banks have been successfully established in the recent years in order to encourage parents to bank their children’s UCB for autologous use or for directed donor allogeneic use for a family member for future purposes.

 UCB can be collected from the placenta during the third stage of labor or after the delivery of placenta. This process does not pose any serious risk to the baby or mother. UCB is collected from the source umbilical vein into a sterile closed system collection bag containing an anticoagulant solution. Then the bag is transported to the cord blood bank, where it is tested, processed and cryopreserved for future purposes. The first publicly funded cord blood bank was established in New York in 1993. Cord blood units stored in public banks are available for the patients in need worldwide. A patient from any corner of the world can access the cord blood units in a public bank through search performed by various registries worldwide, if they get HLA-matched. The donors are not charged for the storage process. The recipients who will be using the cord blood units for their treatment will be charged. In a private bank, UCB is stored privately for a particular family which opts for cord blood storage, and can be utilized by the family as the need arise. As cord blood units stored in private banks are not available for the general population. Developing nations such as China and India being the second most populous country, possesses a great potential in the field of cord blood banking. Certain private cord blood banks in the United States, Belgium, Canada, etc. have adopted the adopted strategy. These adopt various policies in which both public and private banking can be incorporated. A bank might offer both public and private banking and the family are allowed to make an informed decision. Advances are being made each day in providing greater safety to the patient. New methods of separating the stem cells from all other blood components have resulted in a product that consists of only stem cells

Constant attempts are being continuously made to spread awareness of the phenomenon of umbilical blood (stem cell) banking that has created a significant sensation in the population. Another fact is the lack of awareness regarding the utility of cord stem cells and its uses among the general population as well as the medical personnel including the pediatricians and obstetricians. While on the other hand, stringent regulatory requirements, ethical issues and dilemma in choosing private or public bank are the major factors hindering the growth of the market. In addition, high cost of storage, collection and risk of non-usability of the unit stored with private bank are further limiting the growth of the global cord blood banking services market.

Get a sample copy of the Cord Blood Banking Services Market report, visit @ https://www.reportsanddata.com/download-free-sample/2248

Further key findings from the report suggest

• Cord blood banking services market is growing at a CAGR of 2 %in Asia Pacific followed by North America and Europe, with 12.2 % and 11.8 % CAGR, respectively. High cord blood banking services market across the globe is the key factor to accelerate the market growth during forecast period across all regions.
• As of 2018, Cord blood segment is the dominating cord blood banking services market which holds 32.5% of the global market and generates highest revenue.
• Cord tissue and placenta segment are also growing on a high pace and thus covers 27.5% and 30% of the market share with a CAGR of 12.1% and 12.2%.
• Private segment has the highest market share of 35% and was valued at USD 7.49 billion and is expected reach USD 17.83 billion by 2026.
• Hybrid segment has the highest CAGR of 13.3% and hence growing on a high speed in the global forecasts period.
• Asia Pacific is expected to account for the 30% of the global cord blood banking services market. Developing nations such China, and India are likely to witness high growth
• The marketing activities practiced by the private players are resulting in the increased customer base of private players compared to public banks. Considering all the above mentioned factors together, private banking service segment was leading the global market.
• Key participants include China Cord Blood Corporation, Cord Blood America Inc., CBR Systems Inc., Cord life Group Limited, Cryo-Cell International Inc., Cryo-Save AG, Life-force Cry banks, National Cord Blood Program, via cord, Inc. And Virgin Health Bank.

To know more about the latest insights of the report, visit @

https://www.reportsanddata.com/request-latest-insight/2248

For the purpose of this report, Reports and Data have segmented the Anti cord blood banking services market on the basis of service type, application, and region:

 Service Type (Revenue, USD Million; 2018–2028)

• Private
• Public
• Hybrid
• Others

Application (Revenue, USD Million; 2018–2028)

• Cord blood
• Cord tissue
• Placenta
• Others

Regional Outlook (Revenue in USD Million; 2018–2028)

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Spain
• Italy
• Rest of the Europe
• Asia Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Middle East Africa
• Latin America
• Brazil

Request a customized copy of the report @

https://www.reportsanddata.com/request-customization-form/2248

Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  

Browse:

https://www.reportsanddata.com/report-detail/immunohistochemistry-market

https://www.reportsanddata.com/report-detail/hormone-refractory-prostate-cancer-hrpca-market

https://www.reportsanddata.com/report-detail/organ-perfusion-system-market

https://www.reportsanddata.com/report-detail/respiratory-syncytial-virus-diagnostic-market

https://www.reportsanddata.com/report-detail/enteral-feeding-devices-market

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report